Article Details

Roche claims US approval for lymphoma bispecific Lunsumio - - Pharmaphorum

Retrieved on: 2022-12-23 10:39:59

Tags for this article:

Click the tags to see associated articles and topics

Roche claims US approval for lymphoma bispecific Lunsumio - - Pharmaphorum. View article details on hiswai:

Excerpt

FDA approves Roche's CD20xCD3 bispecific antibody Lunsumio for follicular lymphoma, billed as a challenger to CAR-Ts for the blood cancer.

Article found on: pharmaphorum.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up